UPClytics
Overview · Filed: Oct 24, 2024

UPC_APP_58027/2024

FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Procedural & sub-applicationsCosts AssessmentsMilan CDGenericCase Closed
Parties

Claimants

  • Insulet Corporation
Reps: Marc Grunwald

Respondents

  • EOFLOW Co., Ltd.
Reps: Christopher Maierhoefer
Judges
  • Andrea Postiglione
  • Anna-Lena Klein
  • Uwe Schwengelbeck
Patents
  • EP4201327
  • EP 4 201 327
CPC codes: A61M5/1723, A61M5/1452, A61M5/158, A61B5/14865, A61M5/14244, F04B9/02, A61B5/14532, A61M2230/201, A61M2005/14506, A61M5/14248, B65D83/761, A61M5/3291

Sector: Packaging & Conveying

Outcome
Costs only
Filed: Oct 24, 2024
First decided: Dec 23, 2024
Language: English

Milan Central Division costs order in Insulet Corporation v. MENARINI DIAGNOSTICS s.r.l. arising from intervention proceedings (Insulet's application for provisional measures against EOFLOW, EP 4 201 327). The court held: (1) an intervener in sub-proceedings must show a legally qualified interest; (2) intervention under R. 313 RoP is governed by adversarial principle and both intervener applicant and respondent are parties for cost purposes; (3) the successful party preventing or obtaining intervention may claim costs under Art. 69 UPCA; (4) an invoice is not required if the amounts and activities are clear. MENARINI ordered to pay Insulet EUR 1,764 in costs within 15 days.

Open on UPC Registry